Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3- ene-2-one against Mycobacterium tuberculosis

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 13, 2011, Pages 3947-3950

  Mugunthan, G ^a   Ramakrishna, Kuppala ^a   Sriram, Dharmarajan ^b   Yogeeswari, Perumal ^b   Ravindranathan Kartha, K P ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Anti tubercular activity; d Galactose; Enones; Mycobacterium tuberculosis

Indexed keywords

1 (BETA DEXTRO GALACTOPYRANOSYL) 4 (ARYL)BUT 3 ENE 2 ONE; ALPHA GLUCOSIDASE INHIBITOR; CHALCONE DERIVATIVE; CHITIN SYNTHASE; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GLYCOSYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EPIMERIZATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTITUBERCULAR AGENTS; GALACTOSE; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MYCOBACTERIUM TUBERCULOSIS; PYRANS; STRUCTURE-ACTIVITY RELATIONSHIP;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79958711307     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.05.037     Document Type: Article

References (22)

1. Part of this work was presented in CARBO XXV, Recent advances in chemistry and technology of carbohydrates at Shimla, India. November, 2010.
2. World Health Organisation, 2010/2011 Tuberculosis global facts. www.who.int/tb/publications/2010/factsheet-tb-2010.pdf. (Webpage access date: 12.11.2010).
3. Compain, P.; Martin, O. R. Bioorg. Med. Chem. 2001, 9, 3077.
4. Kajimoto, T.; Node, M. Synthesis 2009, 19, 3179.
5. Nowakowska, Z. Eur. J. Med. Chem. 2007, 42, 125.
6. Lin, Y.-M.; Zhou, Y.; Flavin, M. T.; Zhou, L.-M.; Nie, W.; Chen, F.-C. Bioorg. Med. Chem. 2002, 10, 2795.
7. Mascarello, A.; Chiaradia, L. D.; Vernal, J.; Villarino, A.; Guido, R. V. C.; Perizzolo, P.; Poirier, V.; Wong, D.; Martins, P. G. A.; Nunes, R. J.; Yunes, R. A.; Andricopulo, A. D.; Av-Gay, Y.; Terenzi, H. Bioorg. Med. Chem. 2010, 18, 3783.
8. Lopéz, S. N.; Castelli, M. V.; Zacchino, S. A.; Domínuuez, J. N.; Lobo, G.; Charris-Charris, J.; Cortés, J. C. G.; Ribas, J. C.; Devia, C.; Rodríguez, A. M.; Enriz, R. D. Bioorg. Med. Chem. 2001, 9, 1999.
9. Rodrigues, F.; Canac, Y.; Lubineau, A. Chem. Commun. 2000, 2049.
10. Bisht, S. S.; Fatima, S.; Tamrakar, A. K.; Rahuja, N.; Jaiswal, N.; Srivastava, A. K.; Tripathi, R. P. Bioorg. Med. Chem. Lett. 2009, 19, 2699.
11. El-sayed, W. A.; Ramiz, M. M. M.; Abdel-Rahman, A. A.-H. Monatsh. Chem. 2008, 139, 1499.
12. Pederson, L. L.; Turco, S. J. Cell. Mol. Life Sci. 2003, 60, 259.
13. Bragnier, N.; Scherrmann, M.-C. Synthesis 2005, 814.
14. Bisht, S. S.; Pandey, J.; Sharma, A.; Tripathi, R. P. Carbohydr. Res. 2008, 343, 1399.
15. Wang, J.-F.; Lei, M.; Li, Q.; Ge, Z.-M.; Wang, X.; Li, R.-T. Tetrahedron 2009, 65, 4826.
16. Allevi, P.; Anastasia, M.; Ciuffreda, P.; Fiecchi, A.; Scala, A. J. Chem. Soc., Perkin Trans. 1 1989, 1275.
17. Grugier, J.; Xie, J.; Duarte, I.; Valéry, J.-M. J. Org. Chem. 2000, 65, 979.
18. Riemann, I.; Papadopoulos, M. A.; Knorst, M.; Fessner, W.-D. Aust. J. Chem. 2002, 55, 147.
19. Bhagat, S.; Sharma, R.; Sawant, D. M.; Sharma, L.; Chakraborti, A. K. J. Mol. Catal. A: Chem. 2006, 244, 20.
20. +.
21. 7 cfu/mL. A 5 μL amount of bacterial suspension was spotted into 7H11 agar tubes containing 10-fold serial dilutions of drugs per mL. The tubes were incubated at 37°C, and final readings were recorded after 28 days. The minimum inhibitory concentration (MIC) is defined as the minimum concentration of the compound required to give the complete inhibition of bacterial growth.
22. Saito, H.; Tomioka, H.; Sato, K.; Emori, M.; Yamane, T.; Yamashita, K.; Hosol, K.; Hidaka, T. Antimicrob. Agents Chemother. 1991, 35, 542.